01 1Aurobindo Pharma Limited
01 1CEFPROZIL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-24
Pay. Date : 2014-03-24
DMF Number : 18469
Submission : 2005-06-28
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CEFPROZIL USP, with a corresponding US DMF Number 18469.
Remarkably, this DMF maintains an Active status since its submission on June 28, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 24, 2014, and payment made on March 24, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
